Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 45

1.

Influence of Age and Body Mass Index on Total and Segmental Colonic Transit Times in Constipated Subjects.

Bouchoucha M, Fysekidis M, Rompteaux P, Airinei G, Sabate JM, Benamouzig R.

J Neurogastroenterol Motil. 2019 Apr 30;25(2):258-266. doi: 10.5056/jnm18167.

2.

Living with an irritable bowel syndrome

Sabaté JM, Blanchard A, Façon S.

Rev Prat. 2017 Dec;67(10):1095-1096. French. No abstract available.

PMID:
30512609
3.

Clinical and psychological correlates of soiling in adult patients with functional gastrointestinal disorders.

Bouchoucha M, Devroede G, Rompteaux P, Bejou B, Sabate JM, Benamouzig R.

Int J Colorectal Dis. 2018 Dec;33(12):1793-1797. doi: 10.1007/s00384-018-3120-9. Epub 2018 Jul 10.

PMID:
29987361
4.

Association Between Ultra-Processed Food Consumption and Functional Gastrointestinal Disorders: Results From the French NutriNet-Santé Cohort.

Schnabel L, Buscail C, Sabate JM, Bouchoucha M, Kesse-Guyot E, Allès B, Touvier M, Monteiro CA, Hercberg S, Benamouzig R, Julia C.

Am J Gastroenterol. 2018 Aug;113(8):1217-1228. doi: 10.1038/s41395-018-0137-1. Epub 2018 Jun 15.

PMID:
29904158
5.

Invitation letter with a standardized form is a reliable tool to exclude increased risk patients from organized fecal immunological testing-based colorectal cancer screening program.

Sportes A, Catajar N, Charles S, Bejou B, Mary F, Sabaté JM, Le Mab G, Benamouzig R.

Dig Liver Dis. 2018 Dec;50(12):1339-1342. doi: 10.1016/j.dld.2018.02.008. Epub 2018 Mar 6.

PMID:
29571900
6.

The FREGAT biobank: a clinico-biological database dedicated to esophageal and gastric cancers.

Mariette C, Renaud F, Piessen G, Gele P, Copin MC, Leteurtre E, Delaeter C, Dib M, Clisant S, Harter V, Bonnetain F, Duhamel A, Christophe V, Adenis A; Fregat Working Group.

BMC Cancer. 2018 Feb 6;18(1):139. doi: 10.1186/s12885-018-3991-8.

7.

Clinical practice guidelines from the French National Society of Coloproctology in treating chronic constipation.

Vitton V, Damon H, Benezech A, Bouchard D, Brardjanian S, Brochard C, Coffin B, Fathallah N, Higuero T, Jouët P, Leroi AM, Luciano L, Meurette G, Piche T, Ropert A, Sabate JM, Siproudhis L; SNFCP CONSTI Study Group.

Eur J Gastroenterol Hepatol. 2018 Apr;30(4):357-363. doi: 10.1097/MEG.0000000000001080.

PMID:
29406436
8.

Food consumption and dietary intakes in 36,448 adults and their association with irritable bowel syndrome: Nutrinet-Santé study.

Torres MJ, Sabate JM, Bouchoucha M, Buscail C, Hercberg S, Julia C.

Therap Adv Gastroenterol. 2018 Jan 14;11:1756283X17746625. doi: 10.1177/1756283X17746625. eCollection 2018.

9.

High Risk of Anal and Rectal Cancer in Patients With Anal and/or Perianal Crohn's Disease.

Beaugerie L, Carrat F, Nahon S, Zeitoun JD, Sabaté JM, Peyrin-Biroulet L, Colombel JF, Allez M, Fléjou JF, Kirchgesner J, Svrcek M; Cancers et Surrisque Associé aux Maladies Inflammatoires Intestinales En France Study Group.

Clin Gastroenterol Hepatol. 2018 Jun;16(6):892-899.e2. doi: 10.1016/j.cgh.2017.11.041. Epub 2017 Dec 2.

PMID:
29199142
10.

Impact of RAS Mutations in Metastatic Colorectal Cancer After Potentially Curative Resection: Does Site of Metastases Matter?

Passot G, Kim BJ, Glehen O, Mehran RJ, Kopetz SE, Goere D, Overman MJ, Pocard M, Marchal F, Conrad C, Aloia TA, Vauthey JN, Chun YS; BIG-RENAPE Working Group.

Ann Surg Oncol. 2018 Jan;25(1):179-187. doi: 10.1245/s10434-017-6141-7. Epub 2017 Oct 25.

PMID:
29071660
11.

Western Dietary Pattern Is Associated with Irritable Bowel Syndrome in the French NutriNet Cohort.

Buscail C, Sabate JM, Bouchoucha M, Kesse-Guyot E, Hercberg S, Benamouzig R, Julia C.

Nutrients. 2017 Sep 7;9(9). pii: E986. doi: 10.3390/nu9090986.

12.

Association between self-reported vegetarian diet and the irritable bowel syndrome in the French NutriNet cohort.

Buscail C, Sabate JM, Bouchoucha M, Torres MJ, Allès B, Hercberg S, Benamouzig R, Julia C.

PLoS One. 2017 Aug 25;12(8):e0183039. doi: 10.1371/journal.pone.0183039. eCollection 2017.

13.

The effects of aminosalicylates or thiopurines on the risk of colorectal cancer in inflammatory bowel disease.

Carrat F, Seksik P, Colombel JF, Peyrin-Biroulet L, Beaugerie L; CESAME Study Group.

Aliment Pharmacol Ther. 2017 Feb;45(4):533-541. doi: 10.1111/apt.13897. Epub 2016 Dec 19.

14.

Consequences of Small Intestinal Bacterial Overgrowth in Obese Patients Before and After Bariatric Surgery.

Sabate JM, Coupaye M, Ledoux S, Castel B, Msika S, Coffin B, Jouet P.

Obes Surg. 2017 Mar;27(3):599-605. doi: 10.1007/s11695-016-2343-5.

PMID:
27576576
15.

Excess risk of urinary tract cancers in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study.

Bourrier A, Carrat F, Colombel JF, Bouvier AM, Abitbol V, Marteau P, Cosnes J, Simon T, Peyrin-Biroulet L, Beaugerie L; CESAME study group.

Aliment Pharmacol Ther. 2016 Jan;43(2):252-61. doi: 10.1111/apt.13466. Epub 2015 Nov 9.

16.

Early Postoperative Chemotherapy After Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Isolated Peritoneal Carcinomatosis of Colon Cancer: A Multicenter Study.

Maillet M, Glehen O, Lambert J, Goere D, Pocard M, Msika S, Passot G, Elias D, Eveno C, Sabaté JM, Lourenco N, André T, Gornet JM; BIG-RENAPE Working Group.

Ann Surg Oncol. 2016 Mar;23(3):863-9. doi: 10.1245/s10434-015-4914-4. Epub 2015 Oct 19.

PMID:
26480848
17.

Faecal microbiota transplantation in recurrent Clostridium difficile infection: Recommendations from the French Group of Faecal microbiota Transplantation.

Sokol H, Galperine T, Kapel N, Bourlioux P, Seksik P, Barbut F, Scanzi J, Chast F, Batista R, Joly F, Joly AC, Collignon A, Guery B, Beaugerie L; French Group of Faecal microbiota Transplantation (FGFT).

Dig Liver Dis. 2016 Mar;48(3):242-7. doi: 10.1016/j.dld.2015.08.017. Epub 2015 Sep 7.

PMID:
26433619
18.

Factors affecting satisfaction with treatment in European women with chronic constipation: An internet survey.

Emmanuel A, Quigley EM, Simrén M, Feng Y, Müller-Lissner S, Urbain D, Tack J, Bredenoord AJ, Sabaté JM, Yiannakou Y, Andresen V, Cuomo R, Rey E, Gryp RS, Vandeplassche L, Solomon D.

United European Gastroenterol J. 2013 Oct;1(5):375-84. doi: 10.1177/2050640613494200.

19.

Risk of new or recurrent cancer under immunosuppressive therapy in patients with IBD and previous cancer.

Beaugerie L, Carrat F, Colombel JF, Bouvier AM, Sokol H, Babouri A, Carbonnel F, Laharie D, Faucheron JL, Simon T, de Gramont A, Peyrin-Biroulet L; CESAME Study Group.

Gut. 2014 Sep;63(9):1416-23. doi: 10.1136/gutjnl-2013-305763. Epub 2013 Oct 25.

PMID:
24162591
20.

Early administration of azathioprine vs conventional management of Crohn's Disease: a randomized controlled trial.

Cosnes J, Bourrier A, Laharie D, Nahon S, Bouhnik Y, Carbonnel F, Allez M, Dupas JL, Reimund JM, Savoye G, Jouet P, Moreau J, Mary JY, Colombel JF; Groupe d'Etude Thérapeutique des Affections Inflammatoires du Tube Digestif (GETAID).

Gastroenterology. 2013 Oct;145(4):758-65.e2; quiz e14-5. doi: 10.1053/j.gastro.2013.04.048. Epub 2013 Apr 30.

PMID:
23644079

Supplemental Content

Loading ...
Support Center